Veryan Closes £3.6m Funding Round to Develop BioMimics 3D Stent Technology 12 March 2010 Funding will be employed to finance further development and a clinical trial designed to show the clinical benefit of BioMimics 3D™.
Evotec Reports Progress in Product Development in Treatment-Resistant Depression in its Alliance with Roche 11 March 2010 Company completion its first-in-man study with EVT 103 and receives a positive feedback from the FDA to initiate Phase II with EVT 101.
NIH Clinical Trial Comparing Two Stroke Prevention Procedures Shows Surgery and Stenting Equally Safe and Effective 05 March 2010 Physicians will now have more options in tailoring treatments for their patients at risk for stroke.
Spectral Granted IDE Approval by U.S. FDA to Conduct Pivotal Trial for Toraymyxin™ 04 March 2010 The Company will conduct EUPHRATES double-blinded control trial of standard of care versus standard of care.
MorphoSys AG Reports Positive Results for Fiscal Year 2009 03 March 2010 The Company has increased full-year Group revenues by 13 percent to EUR 81.0 million.
Resverlogix Activates First Site for ASSURE 1 Clinical Trial 26 February 2010 Cleveland Clinic coordinates IVUS testing of RVX-208 in acute coronary syndrome patients
Almac Expands Radiolabelling Facilities to Include 14C API and IMP Supply 26 February 2010 Launch of new MHRA audited facility will enable Almac to meet the rapid timelines required by Pharma companies in drug development.
Galapagos Completes Phase I Clinical Trials for Rheumatoid Arthritis Candidate Drug GLPG0259 24 February 2010 Phase II efficacy study in rheumatoid arthritis patients planned to start later this year.